Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Soleus holdings

<< Previous

Bullboard Posts

Next >>

Post by Wino115on Feb 24, 2021 9:02am

172 Views

Post# 32645238

Soleus holdings

I think Spatrap mentioned ESSA PHarma (EPIX) a few weeks ago (prostate cancer drug). That's one of Soleus larger holdings. It's up 5x since summer. Others are Biotla (top holding Dec20), Lantheus, Iveric bio, C4 Therapeutics, Alpine Immune.

Looks like they manage around $700mil in US fund and positions vary from $10-$40mil.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?